GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxford BioDynamics PLC (LSE:OBD) » Definitions » Return-on-Tangible-Asset

Oxford BioDynamics (LSE:OBD) Return-on-Tangible-Asset : -81.40% (As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Oxford BioDynamics Return-on-Tangible-Asset?

Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Oxford BioDynamics's annualized Net Income for the quarter that ended in Mar. 2024 was £-9.45 Mil. Oxford BioDynamics's average total tangible assets for the quarter that ended in Mar. 2024 was £11.61 Mil. Therefore, Oxford BioDynamics's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2024 was -81.40%.

The historical rank and industry rank for Oxford BioDynamics's Return-on-Tangible-Asset or its related term are showing as below:

LSE:OBD' s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -93.09   Med: -22.85   Max: -11.74
Current: -93.09

During the past 11 years, Oxford BioDynamics's highest Return-on-Tangible-Asset was -11.74%. The lowest was -93.09%. And the median was -22.85%.

LSE:OBD's Return-on-Tangible-Asset is ranked worse than
76.45% of 1503 companies
in the Biotechnology industry
Industry Median: -39.32 vs LSE:OBD: -93.09

Oxford BioDynamics Return-on-Tangible-Asset Historical Data

The historical data trend for Oxford BioDynamics's Return-on-Tangible-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxford BioDynamics Return-on-Tangible-Asset Chart

Oxford BioDynamics Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Return-on-Tangible-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only -14.57 -27.26 -47.24 -55.99 -90.38

Oxford BioDynamics Semi-Annual Data
Sep13 Sep14 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24
Return-on-Tangible-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -42.14 -66.67 -79.62 -95.29 -81.40

Competitive Comparison of Oxford BioDynamics's Return-on-Tangible-Asset

For the Biotechnology subindustry, Oxford BioDynamics's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oxford BioDynamics's Return-on-Tangible-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oxford BioDynamics's Return-on-Tangible-Asset distribution charts can be found below:

* The bar in red indicates where Oxford BioDynamics's Return-on-Tangible-Asset falls into.



Oxford BioDynamics Return-on-Tangible-Asset Calculation

Oxford BioDynamics's annualized Return-on-Tangible-Asset for the fiscal year that ended in Sep. 2023 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(A: Sep. 2023 )  (A: Sep. 2022 )(A: Sep. 2023 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(A: Sep. 2023 )  (A: Sep. 2022 )(A: Sep. 2023 )
=-10.826/( (9.743+14.214)/ 2 )
=-10.826/11.9785
=-90.38 %

Oxford BioDynamics's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2024 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(Q: Mar. 2024 )  (Q: Sep. 2023 )(Q: Mar. 2024 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(Q: Mar. 2024 )  (Q: Sep. 2023 )(Q: Mar. 2024 )
=-9.45/( (14.214+9.006)/ 2 )
=-9.45/11.61
=-81.40 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is two times the semi-annual (Mar. 2024) net income data.


Oxford BioDynamics  (LSE:OBD) Return-on-Tangible-Asset Explanation

Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.


Be Aware

Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the company’s earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a company’s tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.


Oxford BioDynamics Return-on-Tangible-Asset Related Terms

Thank you for viewing the detailed overview of Oxford BioDynamics's Return-on-Tangible-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Oxford BioDynamics Business Description

Traded in Other Exchanges
Address
Oxford Business Park South, 3140 Rowan Place, John Smith Drive, Oxford, GBR, OX4 2WB
Oxford BioDynamics PLC is a biotechnology company. The company focuses on the discovery and development of biomarkers for use within the pharmaceutical and biotechnology industry. It provides a technology platform Episwitch which aims to accelerate the drug discovery and development process and improve the success rate of therapeutic product development. Geographically, the majority of revenue is from The United Kingdom.

Oxford BioDynamics Headlines

No Headlines